Amgen Inc.
TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
Last updated:
Abstract:
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
3 Nov 2017
Issue date:
12 Sep 2019